TWI405595B - 對玻尿酸溶液滅菌之方法及經滅菌之玻尿酸水溶液 - Google Patents

對玻尿酸溶液滅菌之方法及經滅菌之玻尿酸水溶液 Download PDF

Info

Publication number
TWI405595B
TWI405595B TW100103169A TW100103169A TWI405595B TW I405595 B TWI405595 B TW I405595B TW 100103169 A TW100103169 A TW 100103169A TW 100103169 A TW100103169 A TW 100103169A TW I405595 B TWI405595 B TW I405595B
Authority
TW
Taiwan
Prior art keywords
hyaluronic acid
solution
weight
aqueous solution
mda
Prior art date
Application number
TW100103169A
Other languages
English (en)
Chinese (zh)
Other versions
TW201200171A (en
Inventor
Xiaojun Michael Liu
David Joseph Heiler
Thomas Menzel
Abbie Brongo
Susan E Burke
Karl Cummins
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of TW201200171A publication Critical patent/TW201200171A/zh
Application granted granted Critical
Publication of TWI405595B publication Critical patent/TWI405595B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
TW100103169A 2010-02-09 2011-01-27 對玻尿酸溶液滅菌之方法及經滅菌之玻尿酸水溶液 TWI405595B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/702,540 US8283463B2 (en) 2010-02-09 2010-02-09 Sterile hyaluronic acid solutions

Publications (2)

Publication Number Publication Date
TW201200171A TW201200171A (en) 2012-01-01
TWI405595B true TWI405595B (zh) 2013-08-21

Family

ID=43754892

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100103169A TWI405595B (zh) 2010-02-09 2011-01-27 對玻尿酸溶液滅菌之方法及經滅菌之玻尿酸水溶液

Country Status (8)

Country Link
US (2) US8283463B2 (enExample)
EP (2) EP2865395A1 (enExample)
JP (1) JP5789271B2 (enExample)
BR (1) BR112012019008B8 (enExample)
ES (1) ES2531955T3 (enExample)
PL (1) PL2400993T3 (enExample)
TW (1) TWI405595B (enExample)
WO (1) WO2011100114A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227289B2 (en) 2010-05-07 2019-03-12 Medicus Biosciences, Llc Methods for treating diseases of the lung
US10111985B2 (en) * 2011-08-10 2018-10-30 Medicus Biosciences, Llc Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
US11083821B2 (en) * 2011-08-10 2021-08-10 C.P. Medical Corporation Biocompatible hydrogel polymer formulations for the controlled delivery of biomolecules
ES2686114T3 (es) * 2011-12-20 2018-10-16 Angioclinic Ag El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas
JP6206987B2 (ja) 2012-05-11 2017-10-04 メディカス バイオサイエンシーズ，エルエルシー 網膜剥離の処置のための生体適合性ヒドロゲル製剤
FR3019465B1 (fr) 2014-04-02 2017-06-23 Horus Pharma Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
ES2837062T3 (es) 2014-04-17 2021-06-29 Merz Pharma Gmbh & Co Kgaa Composición para mejorar el aspecto de la piel envejecida
US10245324B2 (en) 2014-10-31 2019-04-02 Johnson & Johnson Consumer Inc. Ophthalmic composition
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
DE102015226456A1 (de) 2015-12-22 2017-06-22 Heraeus Medical Gmbh Verfahren zur Sterilisation von wässrigen Polysaccharidlösungen und sterile wässrige Polysaccharidlösungen
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
ES2909998T3 (es) * 2016-10-14 2022-05-11 I Com Medical Gmbh Método para establecer, restablecer y preservar la homeostasis de la superficie ocular
ES2975184T3 (es) * 2017-10-12 2024-07-03 Solyplus Gmbh Métodos de fabricación de polímeros masivos concentrados y homogéneamente humectados y aplicaciones de los mismos
CN111196917B (zh) * 2018-11-20 2022-10-14 臧唯 内窥镜用视野清晰剂
US20220273545A1 (en) * 2019-08-21 2022-09-01 Shiseido Company, Ltd. Cosmetic
IT201900019724A1 (it) 2019-10-24 2021-04-24 Bmg Pharma S P A “procedimento in solvente organico per la purificazione dell’acido ialuronico sale sodico”
IT202000008299A1 (it) * 2020-04-17 2021-10-17 Glycores 2000 Srl Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare
KR102549875B1 (ko) * 2020-09-22 2023-07-03 주식회사 필코리아 필러 정제용 장치
CN112255345A (zh) * 2020-10-20 2021-01-22 山东华熙海御生物医药有限公司 一种测定高分子量透明质酸分子量的方法
KR102762718B1 (ko) * 2022-02-23 2025-02-06 주식회사 스카이테라퓨틱스 고분자 히알루론산의 구조체, 이의 제조방법 및 이를 포함하는 화장료 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
WO2001057172A1 (en) * 2000-02-01 2001-08-09 Choongwae Pharma Corporation Composition of multi-purpose solution for treating contact lens
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
WO2009063291A1 (en) * 2007-11-13 2009-05-22 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
DE2837115A1 (de) 1978-08-25 1980-03-06 Bayer Ag Neues verfahren zur herstellung von sterilen feststoffen
RU2067841C1 (ru) * 1994-01-28 1996-10-20 Научно-производственная фирма "Нарт" Способ получения ароматизатора
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US5621093A (en) 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
WO1997033593A1 (en) * 1996-03-15 1997-09-18 Takara Shuzo Co., Ltd. A product of heat treatment of uronic acid, food, drink or drug including the product
KR19980080116A (ko) 1997-03-27 1998-11-25 히라따 다다시 히알루론산 나트륨의 정제법
US6149864A (en) 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
CH692919A5 (fr) 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
FR2811996B1 (fr) * 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
CN1522161A (zh) 2001-06-29 2004-08-18 �Ȱ�ά����ķ�ɷݹ�˾ 批量高压灭菌方法
ATE547122T1 (de) * 2001-11-21 2012-03-15 Novartis Pharma Gmbh Zusammensetzung zur stabilisierung von hyaluronsäure
CN100366296C (zh) 2002-08-07 2008-02-06 梅迪多姆实验室股份有限公司 制备无菌高分子量透明质酸制剂的方法
US6930077B2 (en) 2003-09-10 2005-08-16 Advanced Medical Optics, Inc. Compositions and methods using sub-PPM combinations of polyquaternium-1 and high molecular weight PHMB
US7956180B2 (en) * 2004-05-27 2011-06-07 Novozymes A/S Dried and agglomerated hyaluronic acid product
RU2369408C2 (ru) 2004-07-09 2009-10-10 Ферросан А/С Гемостатическая композиция, включающая гиалуроновую кислоту
DE102005030011A1 (de) 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
EP2346513A1 (en) * 2008-09-15 2011-07-27 Bausch & Lomb Incorporated Compositions comprising polymers having amino sugar units and methods of making and using same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
WO2001057172A1 (en) * 2000-02-01 2001-08-09 Choongwae Pharma Corporation Composition of multi-purpose solution for treating contact lens
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
WO2009063291A1 (en) * 2007-11-13 2009-05-22 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers

Also Published As

Publication number Publication date
EP2400993B1 (en) 2014-12-31
BR112012019008A2 (pt) 2015-09-15
EP2865395A1 (en) 2015-04-29
BR112012019008B1 (pt) 2018-11-13
TW201200171A (en) 2012-01-01
PL2400993T3 (pl) 2015-06-30
US8283463B2 (en) 2012-10-09
US20110195925A1 (en) 2011-08-11
EP2400993A1 (en) 2012-01-04
US8530641B2 (en) 2013-09-10
JP2013518926A (ja) 2013-05-23
BR112012019008B8 (pt) 2018-11-27
WO2011100114A1 (en) 2011-08-18
JP5789271B2 (ja) 2015-10-07
US20120295869A1 (en) 2012-11-22
ES2531955T3 (es) 2015-03-23

Similar Documents

Publication Publication Date Title
EP2400993B1 (en) Sterile hyaluronic acid solutions
Dutta et al. Functional cellulose-based hydrogels as extracellular matrices for tissue engineering
ES2622834T3 (es) Procedimiento de esterilización por filtración en estado diluido para biopolímeros viscoelásticos
EP1753787B1 (en) Method of covalently linking hyaluronan and chitosan
TWI227673B (en) Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
CN102225220A (zh) 眼科手术粘弹剂
WO2010003797A1 (en) Hyaluronic acid for corneal wound healing
US20040127461A1 (en) Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
Ewerton de Oliveira et al. The cooling of blends in water supports durable, thermo-responsive, and porous gelatin-polyphenolic tannin assemblies with antimicrobial activities
JP4597672B2 (ja) 無菌高分子量ヒアルロン酸処方物の製造方法
US20220233745A1 (en) Resorbable implantable device based on crosslinked glycosaminoglycans, and process for the preparation thereof
EP3184550B1 (de) Verfahren zur sterilisation von wässrigen polysaccharidlösungen und sterile wässrige polysaccharidlösungen
CA3075479C (en) Resorbable implantable devices based on crosslinked glycosaminoglycans, and process for the preparation thereof
CN111643519A (zh) 一种伤口消毒液及其制备方法
EP4177276A1 (fr) Composition, sous forme de solution aqueuse comprenant au moins un compose macromoleculaire
HK1080715B (en) Process for preparing a sterile high molecular weight hyaluronic acid formulation